A Study of LY3209590 in Participants With Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

July 6, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

LY3209590

Administered SC

DRUG

Insulin Degludec

Administered SC

Trial Locations (54)

1030

Klinik Landstraße, Vienna

1060

Zentrum für klinische Studien Dr Hanusch Gmbh, Vienna

8036

Universitätsklinikum Graz, Graz

13210

Suny Health Science Center at Syracuse, Syracuse

14612

Praxis Dr. Jörg Lüdemann, Falkensee

15006

Complexo Hospitalario Universitario A Coruña, CHUAC, A Coruña

20852

Endocrine and Metabolic Consultants, Rockville

22607

Diabeteszentrum Hamburg West, Hamburg

23758

RED-Institut GmbH, Oldenburg in Holstein

28401

PMG Research of Wilmington, Wilmington

28557

Lucas Research, Inc., Morehead City

28625

PMG Research of Piedmont Healthcare, Statesville

29010

Hospital Universitario Virgen de la Victoria, Málaga

30076

Endocrine Research Solutions, Inc., Roswell

30318

Atlanta Diabetes Associates, Atlanta

31210

East Coast Institute for Research at The Jones Center, Macon

32204

East Coast Institute for Research at The Jones Center, Jacksonville

33401

Metabolic Research Institute, Inc., West Palm Beach

34652

Sun Coast Clinical Research, Inc, New Port Richey

34655

Bayside Clinical Research, LLC, New Port Richey

37411

Univ Diab & Endo Consult, Chattanooga

37620

Holston Medical Group, Bristol

39120

SMO.MD GmbH, Magdeburg

41003

Clínica nuevas Tecnologías en Diabetes y Endocrinología, Seville

41007

Hospital Universitario Virgen Macarena, Seville

41010

Hospital Quiron Infanta Luisa, Seville

45136

InnoDiab Forschung Gmbh, Essen

46600

Hospital Universitario de La Ribera, Alzira

48145

Institut für Diabetesforschung GmbH Münster, Münster

50265

Iowa Diabetes and Endocrinology Research Center, West Des Moines

66299

Practice Dr.med. Denger and Dr.med. Pfitzner, Friedrichsthal

66386

Zentrum für klinische Studien, Saint Ingbert

70006

Diabetes and Metabolism Associates, APMC, Metairie

73069

Intend Research, LLC, Norman

75149

Southern Endocrinology Associates, Mesquite

75231

Research Institute of Dallas, Dallas

76132

Diabetes and Thyroid Center of Fort Worth, Fort Worth

77095

Endocrine and Psychiatry Center, Houston

78231

Consano Clinical Research, LLC, Shavano Park

78681

Texas Diabetes & Endocrinology, P.A., Round Rock

80045

Barbara Davis Center for Childhood Diabetes, Aurora

80113

Denver Endocrinology, Diabetes & Thyroid Center, Englewood

83404

Rocky Mountain Clinical Research, Idaho Falls

89128

Palm Research Center Tenaya, Las Vegas

93003

Coastal Metabolic Research Centre, Ventura

93720

Valley Endocrine, Fresno, Fresno

94520

John Muir Physician Network Clinical Research Center, Concord

98057

Rainier Clinical Research Center, Renton

03060

Southern Nh Diabetes and Endocrinology, Nashua

78731-4309

Texas Diabetes & Endocrinology, P.A., Austin

00956

Dr Altagracia Aurora Alcantara Gonzalez, Bayamón

00961

Advanced Clinical Research, LLC, Bayamón

00921

Martha Gomez Cuellar M.D., San Juan

04009

Centro Periférico de Especialidades Bola Azul, Almería

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04450407 - A Study of LY3209590 in Participants With Type 1 Diabetes | Biotech Hunter | Biotech Hunter